 |
 |
 |
|
Impact of Archived Minority Populations With M184V/I on
DTG/3TC for Maintenance of Viral Suppression
|
|
|
CROI 2024 March 3-6 Denver
Rosa De Miguel Buckley1, Mayra Sigcha2, Maria de Lagarde2, Jose Luis Blanco3, Rocio Montejano1, Angela Gutiérrez Liarte4, Esperanza Cañas-Ruano5, Arkaitz Imaz6, Cristina Hernández7, Antonio Ocampo Hermida8,Pedro Gil9, Rafael Delgado2, Federico Pulido2, Jose R. Arribas1, for VOLVER-GESIDA 11820 study group
1Hospital Universitario La Paz, Madrid, Spain; 2Hospital Universitario 12 de Octubre, Madrid, Spain; 3Hospital Clinic, Barcelona, Spain;4 Hospital Universitario La Princesa, Madrid, Spain; 5Hospital del Mar, Barcelona, Spain; 6 Hospital Universitario Bellvitge, Barcelona, Spain; 7Hospital Universitario Príncipe de Asturias,Madrid, Spain;8 Hospital Universitario Alvaro Cunqueiro, Vigo, Spain; 9Fundación SEIMC-GeSIDA, Madrid, Spain.




|
|
|
 |
 |
|
|